The COVID-19 rapid test nose swab

Fast and reliable results?
With this COVID-19 Antigen Detection Kit, you have your results in 10-15 minutes.
This rapid test is for oropharynx, nasopharynx, and nose swabs. Our Rapid Test is CE-IVD approved. 

The COVID-19 rapid test nose swab is a test that uses nasopharynx swabs, oropharynx swabs, and nose swabs as samples. This kit adopts the double antibody sandwich methode to qualitative detect noval coronavirus antigens in human spicemens. The Kit uses colloidal gold label anti-human coronavirus monoclonal antibody 1 and 2, and a polyclonal antibody goat anti-mouse IgG. When the tested sample is positieve, the antigen in the specimen binds to the antibody 1 labeled with colloidal gold. The antigen is chromatographed to the detection area and binds to the pre-coated anti-human coronavirus monoclonal antibody 2 to form a double antibody sandwich complex, shich generates a red colour. 


  • Results within 15 minutes
  • Sensitivity 96,86% 
  • Specificity 99,47%
  • Easy to operate
  • No equipment required
  • CE-IVD approved


  • ACCURATE. The double antigen method gives a high accuracy rate
  • ON-SITE. With this kit, it is possible to take a corona test in any place. 

Goffin Molecular Technologies is an authorized distributor of Lituo Biotechnology.

Just like Abbott, Roche, and Quidel, this test is registered in Europe and in possession of a valid CE certificate. This test also meets the minimum requirements of the Spanish RIVM. The Lituo rapid test has now also been officially approved for domestic use in the Czech Republic by the Ministry of Health. And more countries (including Austria) are busy validating this easy quick test. In the Netherlands, the exemption for use as a self-test for consumers has been applied. Due to the non-invasive sample collection, the rapid test is also ideal for use on children, the elderly, persons with disabilities.

Goffin Molecular Technologies is not liable for incorrect use, storage, results, and explanation of the rapid test and any resulting calamities.

Deze test is net zoals Abbott, Roche en Quidel geregistreerd in Europa en in bezit van een geldig CE-certificaat. Ook voldoet deze test aan de minimum eisen van het Spaanse RIVM. De Lituo sneltest is inmiddels ook in Tsjechië door het Ministerie van Volksgezondheid officieel goedgekeurd voor huishoudelijk gebruik. En meer landen (o.a Oostenrijk) zijn druk bezig met het valideren van deze gemakkelijke sneltest. In Nederland is de ontheffing voor gebruik als zelftest voor consumenten aangevraagd. Vanwege de niet-invasieve monsterafname is de sneltest ook ideaal voor gebruik bij kinderen, ouderen, personen met een handicap.

Goffin Molecular Technologies is niet aansprakelijk voor verkeerd gebruik, opslag, uitslag en uitleg van de sneltest en de eventueel daaruit voortvloeiende calamiteiten

Fill in the form

and ask
us anything about our products

After completion, Goffin Molecular Technologies will contact you as soon as possible.